Bausch Health Companies BHC
NYSE BHC
$6.44 -0.37 (-5.43%)
At close: Aug 21, 2026 · 4:00 PM EDT

Bausch Health Companies (BHC) Other Non-Current Liabilities (2009 - 2026)

Bausch Health Companies (BHC) posted Other Non-Current Liabilities of $733.0 million for Q2 2026, down 3.93% sequentially from $763.0 million in Q1 2026, and down 16.42% YoY from $877.0 million in Q2 2025.

Bausch Health Companies (BHC) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends

Bausch Health Companies has reported Other Non-Current Liabilities for 18 years, with the latest figure at $733.0 million in Q2 2026.

  • Quarterly Other Non-Current Liabilities fell 16.42% year-over-year to $733.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $733.0 million (down 16.42% YoY) and the FY2025 annual result came in at $793.0 million, up 11.22% from the prior year.
  • Other Non-Current Liabilities slipped to $733.0 million in Q2 2026 per BHC's latest filing, from $763.0 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $877.0 million in Q2 2025 and troughed at $524.0 million in Q2 2022.
  • A 5-year average of $733.3 million and a median of $745.5 million in 2023 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities plunged 46.26% in 2022, then soared 42.18% in 2023.
  • Over 5 years, Other Non-Current Liabilities stood at $741.0 million in 2022, then increased by 4.72% to $776.0 million in 2023, then declined by 8.12% to $713.0 million in 2024, then gained by 11.22% to $793.0 million in 2025, then dropped by 7.57% to $733.0 million in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $733.0 million, $763.0 million, and $793.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Bausch Health Companies 2.42 Bn 586.38 Mn 2.10 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 733.00 Mn
Mar 31, 2026 763.00 Mn
Dec 31, 2025 793.00 Mn
Sep 30, 2025 843.00 Mn
Jun 30, 2025 877.00 Mn
Mar 31, 2025 761.00 Mn
Dec 31, 2024 713.00 Mn
Sep 30, 2024 805.00 Mn
Jun 30, 2024 745.00 Mn
Mar 31, 2024 751.00 Mn
Dec 31, 2023 776.00 Mn
Sep 30, 2023 721.00 Mn
Jun 30, 2023 745.00 Mn
Mar 31, 2023 746.00 Mn
Dec 31, 2022 741.00 Mn
Sep 30, 2022 619.00 Mn
Jun 30, 2022 524.00 Mn
Mar 31, 2022 544.00 Mn
Dec 31, 2021 653.00 Mn
Sep 30, 2021 872.00 Mn